Prashant Patel
CIK 1617460 · Chief Executive Officer · last filed 2026-06-25
Prashant Patel is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider exercised options on $500 of WGRX on Jun 25, 2026. Across all open-market trades the lifetime net is −$113.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MEDS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
LUTZ, FL 33558
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Wellgistics Health, Inc. (WGRX) Delisted | Chief Executive Officer | 982,365 | $3.52 | $3.46M | $0 | 4 | 2026-06-25 |
| MEDS | Interim CFO and Director | 2,978 | $2.19 | $6.5K | -$113.5K | 7 | 2024-05-28 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | Wellgistics Health, Inc. (WGRX) Delisted | Exer (X) | +100,000 | $500 | EDGAR |
| 2026-06-25 | Wellgistics Health, Inc. (WGRX) Delisted | Grant (A) | +5,000,000 | $1.00M | EDGAR |
| 2026-04-23 | Wellgistics Health, Inc. (WGRX) Delisted | Grant (A) | +5,000,000 | $1.00M | EDGAR |
| 2025-03-25 | Wellgistics Health, Inc. (WGRX) Delisted | Grant (A) | +4,082,247 | $0 | EDGAR |
| 2024-05-28 | MEDS | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-01-16 | MEDS | Grant (A) | +150,000 | $0 | EDGAR |
| 2022-09-16 | MEDS | Grant (A) | +8,620 | $0 | EDGAR |
| 2021-04-20 | MEDS | Sell (S) | −7,500 | -$32.9K | EDGAR |
| 2020-12-16 | MEDS | Sell (S) | −7,500 | -$39.7K | EDGAR |
| 2020-07-21 | MEDS | Sell (S) | −7,500 | -$40.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.